Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling.

Kawamura K, Kawamura N, Okamoto N, Manabe M.

Cancer Med. 2013 Dec;2(6):849-61. doi: 10.1002/cam4.158. Epub 2013 Nov 7.

2.

Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth.

Kawamura N, Kawamura K, Manabe M, Tanaka T.

Endocrinology. 2010 Jul;151(7):3006-14. doi: 10.1210/en.2009-1378. Epub 2010 May 12.

PMID:
20463055
3.

Suppression of hydatidiform molar growth by inhibiting endogenous brain-derived neurotrophic factor/tyrosine kinase B signaling.

Kawamura K, Kawamura N, Kawagoe Y, Kumagai J, Fujimoto T, Terada Y.

Endocrinology. 2012 Aug;153(8):3972-81. doi: 10.1210/en.2012-1167. Epub 2012 Jun 19.

PMID:
22719055
4.

K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.

Ng YK, Wong EY, Lau CP, Chan JP, Wong SC, Chan AS, Kwan MP, Tsao SW, Tsang CM, Lai PB, Chan AT, Lui VW.

Invest New Drugs. 2012 Feb;30(1):48-58. doi: 10.1007/s10637-010-9513-4. Epub 2010 Aug 7.

PMID:
20694504
5.

Brain-derived neurotrophic factor/tyrosine kinase B signaling regulates human trophoblast growth in an in vivo animal model of ectopic pregnancy.

Kawamura K, Kawamura N, Kumazawa Y, Kumagai J, Fujimoto T, Tanaka T.

Endocrinology. 2011 Mar;152(3):1090-100. doi: 10.1210/en.2010-1124. Epub 2011 Jan 14.

PMID:
21239439
6.

Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling.

Makino K, Kawamura K, Sato W, Kawamura N, Fujimoto T, Terada Y.

PLoS One. 2012;7(7):e41049. doi: 10.1371/journal.pone.0041049. Epub 2012 Jul 23.

7.

Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.

Ozono K, Ohishi Y, Onishi H, Nakamura K, Motoshita J, Kato M, Nakanishi R, Nakamura M, Oda Y.

Lab Invest. 2017 Nov;97(11):1332-1342. doi: 10.1038/labinvest.2017.45. Epub 2017 Jun 12.

PMID:
28604655
8.

Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas.

Dubanet L, Bentayeb H, Petit B, Olivrie A, Saada S, de la Cruz-Morcillo MA, Lalloué F, Gourin MP, Bordessoule D, Faumont N, Delage-Corre M, Fauchais AL, Jauberteau MO, Troutaud D.

Br J Cancer. 2015 Sep 15;113(6):934-44. doi: 10.1038/bjc.2015.274. Epub 2015 Aug 18.

9.

Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival.

Akil H, Perraud A, Mélin C, Jauberteau MO, Mathonnet M.

PLoS One. 2011;6(9):e25097. doi: 10.1371/journal.pone.0025097. Epub 2011 Sep 26.

10.
11.

Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain.

Lim JY, Park SI, Kim SM, Jun JA, Oh JH, Ryu CH, Jeong CH, Park SH, Park SA, Oh W, Chang JW, Jeun SS.

Cell Transplant. 2011;20(11-12):1855-66. doi: 10.3727/096368910X557236. Epub 2011 Mar 4.

PMID:
21375801
12.

More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cells.

Guo D, Hou X, Zhang H, Sun W, Zhu L, Liang J, Jiang X.

J Exp Clin Cancer Res. 2011 Oct 14;30:97. doi: 10.1186/1756-9966-30-97.

13.

Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.

Tanaka K, Okugawa Y, Toiyama Y, Inoue Y, Saigusa S, Kawamura M, Araki T, Uchida K, Mohri Y, Kusunoki M.

PLoS One. 2014 May 6;9(5):e96410. doi: 10.1371/journal.pone.0096410. eCollection 2014.

14.

TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma.

Odate S, Nakamura K, Onishi H, Kojima M, Uchiyama A, Nakano K, Kato M, Tanaka M, Katano M.

Lung Cancer. 2013 Mar;79(3):205-14. doi: 10.1016/j.lungcan.2012.12.004. Epub 2013 Jan 9.

PMID:
23312550
15.

[Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].

Zhang JH, Li AM, Chen S, Tong HX, Zhang KR, Zhang JH.

Zhongguo Dang Dai Er Ke Za Zhi. 2008 Feb;10(1):47-50. Chinese.

PMID:
18289471
16.

BDNF-TrkB pathway mediates neuroprotection of hydrogen sulfide against formaldehyde-induced toxicity to PC12 cells.

Jiang JM, Zhou CF, Gao SL, Tian Y, Wang CY, Wang L, Gu HF, Tang XQ.

PLoS One. 2015 Mar 6;10(3):e0119478. doi: 10.1371/journal.pone.0119478. eCollection 2015.

17.

Brain-derived neurotrophic factor promotes implantation and subsequent placental development by stimulating trophoblast cell growth and survival.

Kawamura K, Kawamura N, Sato W, Fukuda J, Kumagai J, Tanaka T.

Endocrinology. 2009 Aug;150(8):3774-82. doi: 10.1210/en.2009-0213. Epub 2009 Apr 16.

PMID:
19372195
18.

Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex.

Sometani A, Kataoka H, Nitta A, Fukumitsu H, Nomoto H, Furukawa S.

J Neurosci Res. 2001 Nov 1;66(3):369-76.

PMID:
11746354
19.

MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.

Pang RT, Leung CO, Lee CL, Lam KK, Ye TM, Chiu PC, Yeung WS.

BMC Cancer. 2013 Jan 18;13:25. doi: 10.1186/1471-2407-13-25.

20.

Tropomyosin-related kinase B inhibitor has potential for tumor regression and relapse prevention in pulmonary large cell neuroendocrine carcinoma.

Odate S, Onishi H, Nakamura K, Kojima M, Uchiyama A, Kato M, Katano M.

Anticancer Res. 2013 Sep;33(9):3699-703.

PMID:
24023298

Supplemental Content

Support Center